| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/24/2010 | US20100158939 Vaccine against pandemic strains of influenza viruses |
| 06/24/2010 | US20100158938 Tetravalent Dengue Vaccines |
| 06/24/2010 | US20100158937 Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-d-manno-octulsonic acid |
| 06/24/2010 | US20100158936 Immunostimulatory compositions and methods |
| 06/24/2010 | US20100158935 Mutant forms of streptolysin o |
| 06/24/2010 | US20100158934 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer |
| 06/24/2010 | US20100158933 Ige ch3 peptide vaccine |
| 06/24/2010 | US20100158932 Antibodies directed against prothrombin fragment F1+2, the preparation and use thereof |
| 06/24/2010 | US20100158931 Novel immunotherapy against several tumors including neuronal and brain tumors |
| 06/24/2010 | US20100158930 Hpv antigen fusion protein vaccine compositions and uses thereof |
| 06/24/2010 | US20100158929 Novel formulations of tumour-associated peptides binding to human leukocyte antigen (hla) class i or class ii molecules for vaccine |
| 06/24/2010 | US20100158928 Immune response modifier compositions and methods |
| 06/24/2010 | US20100158927 Antibodies, methods and kits for diagnosing and treating melanoma |
| 06/24/2010 | US20100158926 Antibodies to erbb2 |
| 06/24/2010 | US20100158925 Lyophilized formulations of anti-egfr antibodies |
| 06/24/2010 | US20100158924 Expression of the cysteine protease legumain in vascular and inflammatory diseases |
| 06/24/2010 | US20100158923 Reducing polyglutamine-based aggregation |
| 06/24/2010 | US20100158922 Anti-Interferon Gamma Antibodies and Methods of Use Thereof |
| 06/24/2010 | US20100158921 Compositions and methods for inhibition of the jak pathway |
| 06/24/2010 | US20100158920 Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
| 06/24/2010 | US20100158919 Pharmaceutical Composition |
| 06/24/2010 | US20100158918 Polypeptides and polynucleotides encoding same |
| 06/24/2010 | US20100158917 Methods for diagnosing cancer and decreasing metastasis by cancer cells |
| 06/24/2010 | US20100158916 Diagnostic biomolecule(s) |
| 06/24/2010 | US20100158915 Method for Diagnosis and Treatment of Pancreatic Cancer |
| 06/24/2010 | US20100158914 Klotho beta |
| 06/24/2010 | US20100158913 Antibody Molecules Having Specificity for Human IL-1B |
| 06/24/2010 | US20100158912 Monitoring and inhibiting human immunodeficiency virus infection by modulating hmgb1 dependent triggering of hiv-1 replication and persistence |
| 06/24/2010 | US20100158911 Compositions and Methods of Treating Disease with FGFR Fusion Proteins |
| 06/24/2010 | US20100158910 Treatment of renal cell carcinoma with anti-cd70 antibody-drug conjugates |
| 06/24/2010 | US20100158909 Variant Target Binding Agents and Uses Thereof |
| 06/24/2010 | US20100158908 Stable Polypeptide Formulations |
| 06/24/2010 | US20100158907 Connective tissue growth factor fragments and methods and uses thereof |
| 06/24/2010 | US20100158906 Use of recombinant monoclonal antibody with specific binding activity for cell surface phosphorylated glycoprotein in diagnosis and treatment of immune, cell proliferative and inflammatory disorders |
| 06/24/2010 | US20100158905 Combination therapy of arthritis with tranilast |
| 06/24/2010 | US20100158904 Treatment with anti-alpha2 integrin antibodies |
| 06/24/2010 | US20100158903 Methods for treating progressive multiple sclerosis |
| 06/24/2010 | US20100158902 Monoclonal antibodies against stromal derived factor-1 (sdf-1) |
| 06/24/2010 | US20100158901 Anti-cd19 antibody therapy for autoimmune disease |
| 06/24/2010 | US20100158900 Anti-marinobufagenin antibodies and methods for their use |
| 06/24/2010 | US20100158899 Protein formulation |
| 06/24/2010 | US20100158898 METHODS OF TREATING IgE-MEDIATED DISORDERS COMPRISING THE ADMINISTRATION OF HIGH CONCENTRATION ANTI-IgE ANTIBODY FORMULATIONS |
| 06/24/2010 | US20100158897 Pai-1 modulators for the treatment of ocular disorders |
| 06/24/2010 | US20100158896 Antibody that specifically binds hyaluronan synthase |
| 06/24/2010 | US20100158895 Methods and compositions for reduction of side effects of therapeutic treatments |
| 06/24/2010 | US20100158894 Preventive or remedy for er-negative and her2-negative breast cancer and method of screening the same |
| 06/24/2010 | US20100158893 Systems and methods for obtaining immunoglobulin from blood |
| 06/24/2010 | US20100158892 Pest control |
| 06/24/2010 | US20100158884 Cascade |
| 06/24/2010 | US20100158881 Activated dual specificity lymphocytes and their methods of use |
| 06/24/2010 | US20100158859 Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue, and/or fever |
| 06/24/2010 | US20100158858 Administration of carboline derivatives useful in the treatment of cancer and other diseases |
| 06/24/2010 | US20100158806 Compositions for Delivery of Therapeutics and Other Materials |
| 06/24/2010 | US20100158803 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies |
| 06/24/2010 | US20100158802 antibody binds target tissue and conjugate carrying epitope (haptens); monoclonal antibody or fragment thereof binds to a colon-specific antigen-p mucin (CSAp) antigen - the Mu-9 epitope; DNA sequence; colon cancer |
| 06/24/2010 | US20100158801 Methods for the treatment of acute myeloid leukemia |
| 06/24/2010 | US20100158796 Amides of hyaluronic acid and the derivatives thereof and a process for their preparation |
| 06/24/2010 | CA2747644A1 Method for generation of immunoglobulin sequences |
| 06/24/2010 | CA2747340A1 Meningococcal vaccines including hemoglobin receptor |
| 06/24/2010 | CA2747219A1 Combination of photodynamic therapy and anti-vegf agents in the treatment of unwanted choroidal neovasculature |
| 06/24/2010 | CA2747064A1 Monoclonal antibodies directed against lg4/5 domain of alpha3 chain of human laminin-5 |
| 06/24/2010 | CA2747062A1 Myostatin binding proteins |
| 06/24/2010 | CA2746340A1 Pcv 2-based methods and compositions for the treatment of pigs |
| 06/24/2010 | CA2746310A1 Methods and compositions for use of a coccidiosis vaccine |
| 06/24/2010 | CA2744624A1 Antibodies against human angiopoietin 2 |
| 06/24/2010 | CA2743433A1 Anti-cmet antibody |
| 06/23/2010 | EP2199795A2 Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
| 06/23/2010 | EP2199400A1 Single recombination system and methods of use |
| 06/23/2010 | EP2199390A1 Anti-epha2 antibody |
| 06/23/2010 | EP2199382A2 Culture medium with yeast or soy bean extract as aminoacid source and no protein complexes of animal origin |
| 06/23/2010 | EP2199307A1 Treatment of chronic joint inflammation using an antibody against the cd3 antigen complex |
| 06/23/2010 | EP2199301A1 Immunogenic polypeptides comprising a scaffold polypeptide and a L2 polypeptide or fragment thereof |
| 06/23/2010 | EP2198922A1 CNS chloride modulation and uses thereof |
| 06/23/2010 | EP2198884A1 Monoclonal antibodies directed against LG4-5 domain of alpha3 chain of human laminin-5 |
| 06/23/2010 | EP2198883A1 In ovo protection against infectious bronchitis |
| 06/23/2010 | EP2198882A2 Nucleic acid mucosal immunization |
| 06/23/2010 | EP2198881A1 Nipah virus vaccines |
| 06/23/2010 | EP2198723A1 Inflammation inhibiting compounds |
| 06/23/2010 | EP2198304A2 Molecules and methods for treatment and detection of diabetes |
| 06/23/2010 | EP2198301A1 Peptide-lipid constructs and their use in diagnostic and therapeutic applications |
| 06/23/2010 | EP2198021A1 Ebi3, dlx5, nptx1 and cdkn3 for target genes of lung cancer therapy and diagnosis |
| 06/23/2010 | EP2198016A1 Porcine adeno-associated viruses |
| 06/23/2010 | EP2197918A1 Combination therapy with type i and type ii anti-cd20 antibodies |
| 06/23/2010 | EP2197916A1 Fixed single injection dosage for ocrelizumab (2h7) |
| 06/23/2010 | EP2197914A1 HUMANIZED ANTIBODIES AGAINST THE ß-AMYLOYD PEPTIDE |
| 06/23/2010 | EP2197911A2 Homogeneous antibody populations |
| 06/23/2010 | EP2197906A1 Fusion polypeptide comprising s-antigen repeat units |
| 06/23/2010 | EP2197491A2 High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection |
| 06/23/2010 | EP2197490A2 Compositions that bind multiple epitopes of igf-1r |
| 06/23/2010 | EP2197489A2 B7 FAMILY MEMBER zB7H6 AND RELATED COMPOSITIONS AND METHODS |
| 06/23/2010 | EP2197488A1 Immune stimulatory oligonucleotide analogs containing modified sugar moieties |
| 06/23/2010 | EP2197485A2 Gas57 mutant antigens and gas57 antibodies |
| 06/23/2010 | EP2197484A2 Compositions comprising pneumococcal antigens |
| 06/23/2010 | EP2197483A1 Pharmaceuticals compositions comprising actinomycete glycerol acyl derivatives antigens, their process of extraction, and their use against tuberculosis |
| 06/23/2010 | EP2197482A2 S-layer protein of a. hydrophila as vaccine in fish |
| 06/23/2010 | EP2197481A2 Composition for treating lung cancer, particularly of non-small lung cancers (nsclc) |
| 06/23/2010 | EP2197474A1 Use of soluble ceacam8 for diagnosing, treating or monitoring diseases, and a method for screening compounds that prevent apoptosis |
| 06/23/2010 | EP2197283A2 Formulations for preservation of rota virus |
| 06/23/2010 | EP1613348B1 Methods for modulating angiogenesis with apelin compositions |
| 06/23/2010 | EP1572748B1 Humanized antibody (h14.18) of the mouse 14.18 antibody binding to gd2 and its fusion with il-2 |